$AWRE

AWARE INC /MA/ (AWRE): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

AWARE INC /MA/ (AWRE) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. 8-K false 0001015739 0001015739 2026-07-15 2026-07-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): July 15,

Original reporting
Published Jul 21, 2026, 8:33 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 21, 2026, 8:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$AWRE
Neutral
medium confidence
Mentioned
$AWRE
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AWRENeutralLow
01

Why it matters

The only new company-specific event is the appointment of James Beecham as a Class I director, plus routine shareholder vote tallies and an equity plan share increase.

02

Market read

Governance and board composition update with no disclosed financial or operational catalyst.

03

What to watch

Traders may overreact to governance headlines; the more decision-relevant items would be any subsequent disclosures tied to strategy, hiring, or customer wins.

Relevance 6/10Novelty 3/10Timing: post-8-K filing, after the July 15 annual meeting

Background

The 8-K reports director/officer matters (Item 5.02) and annual meeting voting results (Item 5.07).

Company-level read

Ticker impact

$AWRENeutralMedium confidence
Context

Aware appointed James Beecham as a Class I director on July 15, 2026, per Item 5.02 of its 8-K.

Expected impact

Low likelihood of a sustained repricing; any reaction is likely limited to governance sentiment.

Evidence & confidence

The filing discloses a director appointment and voting outcomes, but no financial guidance, deal, or operational milestone.

Market effects

Minimal. Director appointment does not disclose new product, contract, or regulatory development.

None indicated.

None indicated.

Counterpoint

The appointment could signal a strategic pivot toward cloud data security, but the 8-K provides no explicit roadmap or measurable commitments.

Key entities

  • Aware, Inc.

    Nasdaq-listed company filing the 8-K.

  • James Beecham

    Appointed as a Class I director on July 15, 2026.

  • Ajay K. Amlani

    Re-elected as a Class III director at the annual meeting.

  • Peter R. Faubert

    Re-elected as a Class III director at the annual meeting.

  • RSM US LLP

    Ratified as independent registered public accounting firm for the fiscal year ending December 31, 2026.

Related articles

$AWREMed

AWARE INC /MA/ (AWRE): Results of Operations and Financial Condition

AWARE INC /MA/ (AWRE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 awre-ex99_1.htm EX-99.1 EX-99.1 EXHIBIT 99.1 Company Contact Delaney Gembis Aware, Inc. 781-687-0300 marketing@aware.com Investor Contact David Traverse Aware, Inc. 781-687-0300 IR@aware.com Aware Reports Second Quarter Financial Results BURLINGTON, MASS. – July 29, 202

$AWREMed

Aware Expands Awareness Platform Capabilities with Key Partnerships to Deliver Smarter Identity Decisions

Aware, Inc. (NASDAQ: AWRE) said it is expanding its Awareness Platform with new biometric orchestration and decisioning features, including integrated ROC (NASDAQ: ROC) matching and Mitek (NASDAQ: MITK) identity verification, enhanced Intelligent Liveness and Intelligent Matching. Aware reported Intelligent Liveness can detect attacks in under two seconds and Intelligent Matching aims for ~10x lower FNMR vs prior generations. General availability is Q3 2026.

$AWREMed

Aware Expands Awareness Platform Capabilities with Key Partnerships to Deliver Smarter Identity Decisions

Aware, Inc. (NASDAQ: AWRE) said it is expanding its Awareness Platform with added biometric orchestration and decisioning features, configurable workflows, and integrated partnerships with ROC (NASDAQ: ROC) and Mitek (NASDAQ: MITK). Aware also announced Intelligent Liveness updates to counter deepfakes and attacks in under two seconds, and Intelligent Matching with ~10× lower FNMR and sub-second 1:N matching. General availability is Q3 2026.

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.